Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Identification of the Prognostic Signatures for Isocitrate Dehydrogenase Mutant Glioma., , , , , , , , , and . CIBCB, page 1-7. IEEE, (2022)Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition., , , , , , , , , and 67 other author(s). Cancer Cell, 25 (3): 393--405 (March 2014)Dissecting the genomic complexity underlying medulloblastoma., , , , , , , , , and 80 other author(s). Nature, 488 (7409): 100--105 (August 2012)Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network, , , , , , , , , and 8 other author(s). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 (34): 5743–5750 (2009)The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary, , , , , , , , , and . Acta Neuropathologica, 131 (6): 803--820 (2016)Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?, , , , , , , , , and 3 other author(s). Clinical cancer research : an official journal of the American Association for Cancer Research, 13 (23): 6933–6937 (2007)Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations., , , , , , , , , and 41 other author(s). Cell, 148 (1-2): 59--71 (January 2012)Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations, , , , , , , , , and 1 other author(s). Clinical cancer research : an official journal of the American Association for Cancer Research, 19 (18): 5146–5157 (2013)Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups, , , , , , , , , and 22 other author(s). Acta Neuropathologica, 129 (5): 679--693 (May 1, 2015)Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients, , , , , , , , , and 725 other author(s). Cancer Cell, 34 (2): 211--224.e6 (August 2018)